Dividend Aristocrats / Kings

Own only the elite handful of companies that have raised their dividend every year for 25 (Aristocrats) or 50+ (Kings) years running.

IncomeDecade+ — buy-and-hold compoundingbeginnerFree

The thesis — why it works

Surviving 25–50 years of raising a dividend through multiple recessions, rate cycles, and industry disruptions is an extraordinarily high bar. Very few businesses clear it, and the ones that do generally share durable moats, real pricing power, and management that treats the streak itself as a discipline device.

The streak is a decades-long, market-verified quality filter — far harder to game than any single year's accounting ratio.
A board that has raised the dividend for decades is strongly incentivised never to be the one that breaks it, which reinforces conservative, shareholder-first capital allocation.
Aristocrat-style portfolios have tended to show below-average volatility and shallower drawdowns, because the underlying businesses are mature, cash generative, and rarely speculative.

When to use it

You want the lowest-maintenance, highest-quality dividend sleeve in a portfolio.
You prioritise capital preservation and steadily growing income over maximum growth or maximum yield.
You have a long horizon and don't need to trade actively.

When to avoid it

You're chasing high current yield — Aristocrats often yield near or below the broad market average.
You expect a large, diversified list — see the India note below; the eligible universe here is genuinely small.
You need short-horizon flexibility.

India note: this is fundamentally a US concept. There is no official, rigorously verified "Nifty/Sensex Dividend Aristocrats" index in India, and few Indian-listed companies have a clean, unbroken 25-year raise streak on public record — crises like 2008–09 and 2020 caused genuine freezes and cuts even at otherwise strong companies. Treat this SOP as "find the longest, cleanest dividend streaks actually available in India" rather than a literal Aristocrats index, and verify every streak yourself rather than trusting any list — including well-known long-run payers in FMCG/consumer staples — on faith.

The screen (Screener.in)

Criterion	Rule	Why
Market cap	`> ₹10,000 Cr`	Aristocrat-type names are large, established, index-relevant
Dividend yield	`> 0.5%`	confirms an active, meaningful payer
Return on equity	`> 20%`	high, durable profitability typical of decades-long compounders
Debt to equity	`< 0.3`	low leverage — balance sheet strength to protect the streak
Profit growth 10Years	`> 8%`	sustained, multi-decade earnings growth funding the raises
Sales growth 10Years	`> 8%`	durable top-line growth, not just cost-cutting

Market Capitalization > 10000 AND
Dividend yield > 0.5 AND
Return on equity > 20 AND
Debt to equity < 0.3 AND
Profit growth 10Years > 8 AND
Sales growth 10Years > 8

This is a quality/longevity pre-filter, not a streak-verification tool — Screener.in has no "consecutive years raised" field. Every survivor must be checked by hand.

The procedure

Run the screen.
For each survivor, pull the year-by-year dividend-per-share history as far back as you can find it (10 years minimum from Screener.in; go to annual reports for longer history).
Discard anything with even one flat-to-lower dividend year — a true Aristocrat has zero cuts and, by the strict definition, zero freezes.
Rank what remains by length of verified streak, then by 10-year dividend CAGR.
Buy the survivors as a concentrated sleeve — expect fewer than 10–15 names to genuinely qualify in India — equal- or modestly cap-weighted.

Decision & risk rules

Position size: 5–10% each, given the small eligible universe.
Holding period: multi-year, default hold-forever unless the streak breaks.
Rebalance: annual streak re-verification.
Exit/invalidation: any dividend cut or freeze ends the "Aristocrat" thesis for that name immediately — sell, or reclassify it under ordinary Dividend Growth instead.

Common mistakes

Assuming a well-known dividend payer is automatically a verified streak-holder without checking the actual year-by-year record.
Overpaying — Aristocrat status says nothing about valuation; a rich price can still deliver a poor forward return from a great business.
Treating a freeze during a genuine crisis (e.g., 2020) as permanently disqualifying rather than reassessing the streak fresh from that point.